Insider · CIK 0001842618
Alice Shih-hou Huang
Files at RGLS (Regulus Therapeutics Inc.). First filing -, latest -.
In brief
Alice Shih-hou Huang files SEC Form 4 as director at RGLS (Regulus Therapeutics Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Alice Shih-hou Huang has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 20 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | UTender of shares Common Stock | -5,208 | - | - | 57,292 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Common Stock | -57,292 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | UTender of shares Common Stockindirect: By Spouse | -27,377 | - | - | 57,292 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Common Stockindirect: By Spouse | -57,292 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -4,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -9,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -30,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -15,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -30,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -60,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivativeindirect: By Spouse | -4,650 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivativeindirect: By Spouse | -2,325 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivativeindirect: By Spouse | -4,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivativeindirect: By Spouse | -9,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivativeindirect: By Spouse | -30,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivativeindirect: By Spouse | -15,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivativeindirect: By Spouse | -30,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivativeindirect: By Spouse | -60,000 | - | - | 0 | Jun 27, 2025 |
| Apr 30, 2025 | RGLS Regulus Therapeutics Inc. | AGrant or award Common Stock | +62,500 | $0.00 | $0 | 62,500 | Apr 30, 2025 |
| Apr 30, 2025 | RGLS Regulus Therapeutics Inc. | AGrant or award Common Stockindirect: By Spouse | +62,500 | $0.00 | $0 | 84,669 | Apr 30, 2025 |
Questions about Alice Shih-hou Huang
Answered from the filings on this page, as of the latest one.
Is Alice Shih-hou Huang buying or selling?
Alice Shih-hou Huang has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Alice Shih-hou Huang's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Alice Shih-hou Huang has 0.
Where does Alice Shih-hou Huang file Form 4?
Alice Shih-hou Huang has filed Form 4 at RGLS (Regulus Therapeutics Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.